PortfoliosLab logoPortfoliosLab logo
HOLN.SW vs. NOVN.SW
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

HOLN.SW vs. NOVN.SW - Performance Comparison

The chart below illustrates the hypothetical performance of a CHF 10,000 investment in Holcim AG (HOLN.SW) and Novartis AG (NOVN.SW). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

HOLN.SW vs. NOVN.SW - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
HOLN.SW
Holcim AG
-16.51%80.88%37.03%43.86%7.91%-0.89%-4.36%48.64%-23.52%6.14%
NOVN.SW
Novartis AG
13.63%27.98%8.44%11.93%8.75%-0.11%-5.39%28.50%6.51%16.04%

Returns By Period

In the year-to-date period, HOLN.SW achieves a -16.51% return, which is significantly lower than NOVN.SW's 13.63% return. Over the past 10 years, HOLN.SW has outperformed NOVN.SW with an annualized return of 16.15%, while NOVN.SW has yielded a comparatively lower 12.04% annualized return.


HOLN.SW

1D
-0.28%
1M
-8.41%
YTD
-16.51%
6M
-3.59%
1Y
39.61%
3Y*
34.26%
5Y*
22.76%
10Y*
16.15%

NOVN.SW

1D
0.87%
1M
-4.57%
YTD
13.63%
6M
24.39%
1Y
27.29%
3Y*
19.02%
5Y*
13.69%
10Y*
12.04%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HOLN.SW vs. NOVN.SW — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HOLN.SW
HOLN.SW Risk / Return Rank: 7575
Overall Rank
HOLN.SW Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
HOLN.SW Sortino Ratio Rank: 7575
Sortino Ratio Rank
HOLN.SW Omega Ratio Rank: 7777
Omega Ratio Rank
HOLN.SW Calmar Ratio Rank: 6868
Calmar Ratio Rank
HOLN.SW Martin Ratio Rank: 7373
Martin Ratio Rank

NOVN.SW
NOVN.SW Risk / Return Rank: 7878
Overall Rank
NOVN.SW Sharpe Ratio Rank: 8282
Sharpe Ratio Rank
NOVN.SW Sortino Ratio Rank: 7474
Sortino Ratio Rank
NOVN.SW Omega Ratio Rank: 7777
Omega Ratio Rank
NOVN.SW Calmar Ratio Rank: 7575
Calmar Ratio Rank
NOVN.SW Martin Ratio Rank: 8282
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HOLN.SW vs. NOVN.SW - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Holcim AG (HOLN.SW) and Novartis AG (NOVN.SW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HOLN.SWNOVN.SWDifference

Sharpe ratio

Return per unit of total volatility

1.27

1.35

-0.08

Sortino ratio

Return per unit of downside risk

1.85

1.71

+0.14

Omega ratio

Gain probability vs. loss probability

1.26

1.26

0.00

Calmar ratio

Return relative to maximum drawdown

1.26

1.76

-0.51

Martin ratio

Return relative to average drawdown

4.03

6.41

-2.38

HOLN.SW vs. NOVN.SW - Sharpe Ratio Comparison

The current HOLN.SW Sharpe Ratio is 1.27, which is comparable to the NOVN.SW Sharpe Ratio of 1.35. The chart below compares the historical Sharpe Ratios of HOLN.SW and NOVN.SW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


HOLN.SWNOVN.SWDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.27

1.35

-0.08

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.96

0.78

+0.17

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.63

0.67

-0.03

Sharpe Ratio (All Time)

Calculated using the full available price history

0.29

0.49

-0.21

Correlation

The correlation between HOLN.SW and NOVN.SW is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

HOLN.SW vs. NOVN.SW - Dividend Comparison

HOLN.SW's dividend yield for the trailing twelve months is around 2.43%, less than NOVN.SW's 3.06% yield.


TTM20252024202320222021202020192018201720162015
HOLN.SW
Holcim AG
2.43%2.03%3.21%3.79%4.59%4.30%4.11%11.05%4.94%3.64%2.80%7.43%
NOVN.SW
Novartis AG
3.06%3.19%3.72%3.77%3.91%3.94%3.72%3.27%3.98%3.98%4.35%3.58%

Drawdowns

HOLN.SW vs. NOVN.SW - Drawdown Comparison

The maximum HOLN.SW drawdown since its inception was -76.45%, which is greater than NOVN.SW's maximum drawdown of -42.25%. Use the drawdown chart below to compare losses from any high point for HOLN.SW and NOVN.SW.


Loading graphics...

Drawdown Indicators


HOLN.SWNOVN.SWDifference

Max Drawdown

Largest peak-to-trough decline

-76.45%

-42.25%

-34.20%

Max Drawdown (1Y)

Largest decline over 1 year

-24.70%

-15.71%

-8.99%

Max Drawdown (5Y)

Largest decline over 5 years

-27.64%

-16.86%

-10.78%

Max Drawdown (10Y)

Largest decline over 10 years

-46.18%

-24.11%

-22.07%

Current Drawdown

Current decline from peak

-20.93%

-4.57%

-16.36%

Average Drawdown

Average peak-to-trough decline

-23.78%

-11.42%

-12.36%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.72%

4.37%

+3.35%

Volatility

HOLN.SW vs. NOVN.SW - Volatility Comparison

Holcim AG (HOLN.SW) has a higher volatility of 8.87% compared to Novartis AG (NOVN.SW) at 5.96%. This indicates that HOLN.SW's price experiences larger fluctuations and is considered to be riskier than NOVN.SW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


HOLN.SWNOVN.SWDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.87%

5.96%

+2.91%

Volatility (6M)

Calculated over the trailing 6-month period

21.12%

13.27%

+7.85%

Volatility (1Y)

Calculated over the trailing 1-year period

31.70%

20.53%

+11.17%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.89%

17.51%

+6.38%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.56%

18.16%

+7.40%

Financials

HOLN.SW vs. NOVN.SW - Financials Comparison

This section allows you to compare key financial metrics between Holcim AG and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in CHF except per share items